Functional variant ANXA11 R230C: true marker of protection and candidate disease modifier in sarcoidosis

Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999

Statement on sarcoidosis · American Journal of Respiratory and Critical Care Medicine · 1999 · 2K citations

Medicine, Internal Medicine, Pulmonary Function Testing +6

STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement

Julian Little, Julian P. T. Higgins, John P. A. Ioannidis et al. · PLoS Medicine · 2009 · 783 citations · Full text

Public Health, Biostatistics, Genetics +9

Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis

Sylvia Hofmann, André Franke, Annegret Fischer et al. · Nature Genetics · 2008 · 272 citations

Life Sciences, Genetics, Molecular Genetics +11

Characterisation and protein expression profiling of annexins in colorectal cancer

Ryan D. Duncan, Brian Carpenter, Laura Main et al. · British Journal of Cancer · 2007 · 209 citations · Full text

Medicine, Cancer Biology, Oncology +17

Annexin 11 is required for midbody formation and completion of the terminal phase of cytokinesis

Alejandra Tomás, Clare E. Futter, Stephen E. Moss · The Journal of Cell Biology · 2004 · 105 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16